Squarepoint’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
27,072
-371,153
-93% -$16M ﹤0.01% 2648
2025
Q4
$17.5M Buy
+398,225
New +$16.5M 0.02% 804
2025
Q3
Sell
-25,613
Closed -$1.03M 4527
2025
Q2
$1.13M Buy
25,613
+16,913
+194% +$676K ﹤0.01% 2561
2025
Q1
$321K Sell
8,700
-310,337
-97% -$11.1M ﹤0.01% 3692
2024
Q4
$10.6M Buy
319,037
+150,713
+90% +$4.89M 0.01% 1113
2024
Q3
$4.37M Buy
168,324
+78,875
+88% +$1.96M 0.01% 1497
2024
Q2
$2.01M Buy
89,449
+63,352
+243% +$1.41M ﹤0.01% 2053
2024
Q1
$619K Sell
26,097
-18,268
-41% -$406K ﹤0.01% 2903
2023
Q4
$1.06M Sell
44,365
-22,343
-33% -$486K ﹤0.01% 2475
2023
Q3
$1.46M Buy
66,708
+12,019
+22% +$251K ﹤0.01% 2050
2023
Q2
$1.05M Buy
+54,689
New +$1.05M ﹤0.01% 2130
2023
Q1
Sell
-22,299
Closed -$358K 3380
2022
Q4
$358K Buy
+22,299
New +$364K ﹤0.01% 2472
2022
Q2
Sell
-79,619
Closed -$1.8M 3024
2022
Q1
$1.8M Sell
79,619
-20,951
-21% -$409K 0.01% 1213
2021
Q4
$1.84M Sell
100,570
-259,142
-72% -$4.96M ﹤0.01% 1306
2021
Q3
$7.6M Buy
359,712
+88,635
+33% +$1.65M 0.02% 609
2021
Q2
$4.94M Sell
271,077
-89,525
-25% -$2.09M 0.02% 730
2021
Q1
$8.15M Buy
360,602
+259,595
+257% +$5.86M 0.05% 434
2020
Q4
$2.03M Buy
101,007
+41,980
+71% +$879K 0.02% 935
2020
Q3
$1.44M Sell
59,027
-334,997
-85% -$7.82M 0.02% 804
2020
Q2
$9.35M Buy
394,024
+223,980
+132% +$5.19M 0.15% 183
2020
Q1
$2.93M Sell
170,044
-541,785
-76% -$9.91M 0.07% 340
2019
Q4
$12.5M Buy
711,829
+406,051
+133% +$6.88M 0.07% 236
2019
Q3
$5.41M Buy
305,778
+194,446
+175% +$3.94M 0.05% 455
2019
Q2
$2.38M Buy
+111,332
New +$2.33M 0.02% 752
2019
Q1
Sell
-77,356
Closed -$1.52M 2233
2018
Q4
$1.52M Sell
77,356
-16,392
-17% -$292K 0.02% 769
2018
Q3
$1.66M Sell
93,748
-325,274
-78% -$6.34M 0.02% 787
2018
Q2
$9.02M Buy
419,022
+291,297
+228% +$6.02M 0.12% 254
2018
Q1
$2.83M Sell
127,725
-145,277
-53% -$4.02M 0.04% 456
2017
Q4
$8.3M Buy
273,002
+32,530
+14% +$865K 0.14% 158
2017
Q3
$5.83M Sell
240,472
-98,861
-29% -$2.63M 0.11% 232
2017
Q2
$8.36M Buy
339,333
+255,250
+304% +$5.4M 0.16% 152
2017
Q1
$1.82M Buy
84,083
+27,037
+47% +$550K 0.05% 416
2016
Q4
$851K Buy
57,046
+7,646
+15% +$110K 0.03% 568
2016
Q3
$632K Buy
49,400
+27,400
+125% +$296K 0.04% 485
2016
Q2
$172K Sell
22,000
-32,513
-60% -$187K 0.01% 918
2016
Q1
$218K Sell
54,513
-121,387
-69% -$514K 0.02% 963
2015
Q4
$992K Buy
+175,900
New +$984K 0.11% 263

Other funds holding EXEL

Squarepoint's EXEL Position: Q1 2026 in Review

Squarepoint reduced its Exelixis (EXEL) stake by 93% in Q1 2026, selling an estimated $16M and leaving 27,072 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

Squarepoint first reported a position in EXEL in Q4 2015 and has held it in 37 quarters since. The position peaked at $17.5M in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Squarepoint held 27,072 shares of Exelixis worth $1.16M as of Q1 2026.
  • Squarepoint sold 371,153 Exelixis shares in Q1 2026, an estimated $16M.
  • Exelixis made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2648 holding.
  • Squarepoint first reported a position in Exelixis in Q4 2015 and has held it in 37 quarters since.
  • Squarepoint's Exelixis position peaked at $17.5M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.